Rigel Pharmaceuticals (RIGL): Q2 EPS of -$0.35 misses by $0.01. Revenue of $1.15M (+279% Y/Y). (PR)

|About: Rigel Pharmaceuticals, Inc. (RIGL)|By:, SA News Editor
Rigel Pharmaceuticals (RIGL): Q2 EPS of -$0.35 misses by $0.01. Revenue of $1.15M (+279% Y/Y). (PR)